Time trend analysis and variations in prescribing lipid lowering drugs in general practice.
作者信息
Baxter C, Jones R, Corr L
机构信息
Department of Cardiology, St Thomas's Hospital, London SE1 7EH.
出版信息
BMJ. 1998 Oct 24;317(7166):1134-5. doi: 10.1136/bmj.317.7166.1134.
Abstract
摘要
相似文献
1
Time trend analysis and variations in prescribing lipid lowering drugs in general practice.全科医疗中降脂药物处方的时间趋势分析及变化
BMJ. 1998 Oct 24;317(7166):1134-5. doi: 10.1136/bmj.317.7166.1134.
2
Treatment of Dyslipidemia in Elderly Patients With Coronary Heart Disease: There Are Miles to Go Before We Sleep.老年冠心病患者血脂异常的治疗：路漫漫其修远兮。
J Am Coll Cardiol. 2015 Oct 27;66(17):1873-5. doi: 10.1016/j.jacc.2015.06.1356.
3
Comparison of physician-managed lipid-lowering care in patients with coronary heart disease in two time periods (1994 and 1999).两个时间段（1994年和1999年）冠心病患者由医生管理的降脂治疗比较。
Am J Cardiol. 2001 Dec 15;88(12):1417-9, A6. doi: 10.1016/s0002-9149(01)02124-5.
4
Explaining variations in general practice prescribing costs per ASTRO-PU (age, sex, and temporary resident originated prescribing unit).解释每个ASTRO-PU（年龄、性别和临时居民来源的处方单位）在全科医疗处方成本上的差异。
BMJ. 1996 Feb 24;312(7029):488-9. doi: 10.1136/bmj.312.7029.488.
5
Trends in the Use of Nonstatin Lipid-Lowering Therapy Among Patients With Coronary Heart Disease: A Retrospective Cohort Study in the Medicare Population 2007 to 2011.2007 年至 2011 年 Medicare 人群中冠心病患者使用非他汀类降脂治疗的趋势：一项回顾性队列研究。
J Am Coll Cardiol. 2015 Oct 27;66(17):1864-72. doi: 10.1016/j.jacc.2015.08.042.
6
Use of statins in general practices, 1996-8: cross sectional study.1996 - 1998年全科医疗中他汀类药物的使用：横断面研究
BMJ. 2000 Jun 10;320(7249):1583-4. doi: 10.1136/bmj.320.7249.1583.
7
Trends in antibiotic prescribing.抗生素处方趋势。
J Public Health Med. 2001 Dec;23(4):357. doi: 10.1093/pubmed/23.4.357.
8
Prescribing incentive schemes in two NHS regions: cross sectional survey.英国国家医疗服务体系（NHS）两个地区的处方激励计划：横断面调查
BMJ. 2002 May 18;324(7347):1187-8. doi: 10.1136/bmj.324.7347.1187.
9
Recent trends in the consumption of lipid-lowering drugs in Finland.芬兰降脂药物消费的近期趋势。
J Clin Epidemiol. 1996 Dec;49(12):1453-57. doi: 10.1016/s0895-4356(96)00267-3.
10
Use of lipid-lowering drugs in restricted health access settings: Results from the Trends in Drug Utilization During COVID-19 Pandemic in Turkey (PANDUTI-TR) study.在医疗资源受限环境中使用降脂药物：土耳其新冠疫情期间药物利用趋势（PANDUTI - TR）研究结果
Vascul Pharmacol. 2024 Sep;156:107382. doi: 10.1016/j.vph.2024.107382. Epub 2024 May 28.
引用本文的文献
1
Long-term statin adherence in patients after hospital discharge for new onset of atherosclerotic cardiovascular disease: a population-based study of real world prescriptions in Taiwan.新发动脉粥样硬化性心血管疾病患者出院后长期他汀类药物依从性：一项基于台湾地区真实世界处方的人群研究。
BMC Cardiovasc Disord. 2019 Mar 15;19(1):62. doi: 10.1186/s12872-019-1032-4.
2
Visualizing nationwide variation in medicare Part D prescribing patterns.可视化医疗保险处方模式的全国性差异。
BMC Med Inform Decis Mak. 2018 Nov 19;18(1):103. doi: 10.1186/s12911-018-0670-2.
3
Initiation rates of statin therapy for the primary prevention of cardiovascular disease: an assessment of differences between countries of the UK and between regions within England.他汀类药物用于心血管疾病一级预防的起始治疗率：英国不同国家之间以及英格兰不同地区之间差异的评估。
BMJ Open. 2015 Mar 6;5(3):e007207. doi: 10.1136/bmjopen-2014-007207.
4
Variation in prescribing of lipid-lowering medication in primary care is associated with incidence of cardiovascular disease and all-cause mortality in people with screen-detected diabetes: findings from the ADDITION-Denmark trial.初级保健中降脂药物处方的差异与筛查发现的糖尿病患者的心血管疾病发病率和全因死亡率相关：来自丹麦ADDITION试验的结果。
Diabet Med. 2014 Dec;31(12):1577-85. doi: 10.1111/dme.12574. Epub 2014 Sep 29.
5
Shift of statin use towards the elderly in 1995-2005: a nation-wide register study in Finland.1995 - 2005年他汀类药物使用向老年人的转变：芬兰一项全国性登记研究
Br J Clin Pharmacol. 2008 Sep;66(3):405-10. doi: 10.1111/j.1365-2125.2008.03258.x.
6
Trends in total cholesterol screening and in prescribing lipid-lowering drugs in general practice in the period 1994-2003.1994年至2003年期间全科医疗中总胆固醇筛查及降脂药物处方的趋势。
BMC Fam Pract. 2008 Jun 30;9:39. doi: 10.1186/1471-2296-9-39.
7
Differential associations between actual and expected GP practice prescribing rates for statins, ACE inhibitors, and beta-blockers: a cross-sectional study in England.实际和预期的全科医生处方他汀类药物、ACE 抑制剂和β受体阻滞剂的比率之间的差异关联：英格兰的一项横断面研究。
Ther Clin Risk Manag. 2005 Mar;1(1):61-8. doi: 10.2147/tcrm.1.1.61.53599.
8
How equitable are GP practice prescribing rates for statins?: an ecological study in four primary care trusts in North West England.全科医生开具他汀类药物的处方率有多公平？：对英格兰西北部四个初级保健信托基金的一项生态学研究。
Int J Equity Health. 2007 Mar 27;6:2. doi: 10.1186/1475-9276-6-2.
9
Effectiveness of statins for secondary prevention in elderly patients after acute myocardial infarction: an evaluation of class effect.他汀类药物对老年急性心肌梗死后患者二级预防的有效性：类效应评估
CMAJ. 2005 Apr 26;172(9):1187-94. doi: 10.1503/cmaj.1041403.
10
Exploring the equity of GP practice prescribing rates for selected coronary heart disease drugs: a multiple regression analysis with proxies of healthcare need.探索全科医生对选定冠心病药物的处方率公平性：一项使用医疗需求代理变量的多元回归分析
Int J Equity Health. 2005 Feb 8;4(1):3. doi: 10.1186/1475-9276-4-3.
本文引用的文献
1
The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators.普伐他汀对胆固醇水平正常的心肌梗死患者冠状动脉事件的影响。胆固醇与再发事件试验研究人员。
N Engl J Med. 1996 Oct 3;335(14):1001-9. doi: 10.1056/NEJM199610033351401.
2
A British Cardiac Society survey of the potential for the secondary prevention of coronary disease: ASPIRE (Action on Secondary Prevention through Intervention to Reduce Events).英国心脏病学会关于冠心病二级预防潜力的调查：ASPIRE（通过干预减少事件进行二级预防行动）。
Heart. 1996 Apr;75(4):334-42. doi: 10.1136/hrt.75.4.334.
Zotero 插件